Cargando…

Serum amyloid A and other clinicopathological variables in cats with intermediate- and large-cell lymphoma

OBJECTIVES: Serum amyloid A (SAA) concentrations are increased in cats with lymphoma vs healthy cats; however, the association between SAA concentrations and prognosis in cats with lymphoma is unclear. The aim of this study was to evaluate if SAA concentrations were different in cats with nasal vs n...

Descripción completa

Detalles Bibliográficos
Autores principales: Schiavo, Luca, Odatzoglou, Petros, Hare, Cassia, Williams, Tim L, Dobson, Jane M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742919/
https://www.ncbi.nlm.nih.gov/pubmed/36416277
http://dx.doi.org/10.1177/1098612X221135118
_version_ 1784848623106785280
author Schiavo, Luca
Odatzoglou, Petros
Hare, Cassia
Williams, Tim L
Dobson, Jane M
author_facet Schiavo, Luca
Odatzoglou, Petros
Hare, Cassia
Williams, Tim L
Dobson, Jane M
author_sort Schiavo, Luca
collection PubMed
description OBJECTIVES: Serum amyloid A (SAA) concentrations are increased in cats with lymphoma vs healthy cats; however, the association between SAA concentrations and prognosis in cats with lymphoma is unclear. The aim of this study was to evaluate if SAA concentrations were different in cats with nasal vs non-nasal lymphoma, if SAA concentrations are prognostic in patients treated with high-dose chemotherapy and if SAA concentrations are correlated with other clinicopathological variables. METHODS: Cats diagnosed with intermediate- or large-cell lymphoma between 2012 and 2022 with SAA concentration data available were included. Associations between tumour site (nasal vs non-nasal), stage, response to treatment and SAA concentration were evaluated using non-parametric statistics. Associations between SAA concentrations and stage with survival time were evaluated using Cox regression analysis. Patients with nasal tumours and those not receiving high-dose chemotherapy were excluded from the survival analyses. RESULTS: Thirty-nine cats were included. Median SAA concentrations were significantly higher in non-nasal compared with nasal lymphoma (42 µg/ml [range <0.3–797] vs <0.3 µg/ml [range <0.3–0.9]; P = 0.026). SAA concentrations did not correlate with tumour stage. Median survival time for patients with non-nasal tumour and undergoing chemotherapy was 49 days (range 2–1726). Responders had a better median survival time than non-responders (273 days [range 43–1728] vs 39 days [range 2–169]; P <0.001), whereas SAA concentrations were not associated with survival time. Lower haematocrit at presentation was associated with a reduced median survival time (P = 0.007). CONCLUSIONS AND RELEVANCE: In the population examined, no correlation between serum concentration of SAA and prognosis in patients with lymphoma was identified, while low haematocrit and lack of response to treatment were both found to be associated with survival time. SAA concentrations were elevated in patients with non-nasal lymphoma vs patients with tumours confined to the nasal cavity.
format Online
Article
Text
id pubmed-9742919
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-97429192022-12-13 Serum amyloid A and other clinicopathological variables in cats with intermediate- and large-cell lymphoma Schiavo, Luca Odatzoglou, Petros Hare, Cassia Williams, Tim L Dobson, Jane M J Feline Med Surg Original Articles OBJECTIVES: Serum amyloid A (SAA) concentrations are increased in cats with lymphoma vs healthy cats; however, the association between SAA concentrations and prognosis in cats with lymphoma is unclear. The aim of this study was to evaluate if SAA concentrations were different in cats with nasal vs non-nasal lymphoma, if SAA concentrations are prognostic in patients treated with high-dose chemotherapy and if SAA concentrations are correlated with other clinicopathological variables. METHODS: Cats diagnosed with intermediate- or large-cell lymphoma between 2012 and 2022 with SAA concentration data available were included. Associations between tumour site (nasal vs non-nasal), stage, response to treatment and SAA concentration were evaluated using non-parametric statistics. Associations between SAA concentrations and stage with survival time were evaluated using Cox regression analysis. Patients with nasal tumours and those not receiving high-dose chemotherapy were excluded from the survival analyses. RESULTS: Thirty-nine cats were included. Median SAA concentrations were significantly higher in non-nasal compared with nasal lymphoma (42 µg/ml [range <0.3–797] vs <0.3 µg/ml [range <0.3–0.9]; P = 0.026). SAA concentrations did not correlate with tumour stage. Median survival time for patients with non-nasal tumour and undergoing chemotherapy was 49 days (range 2–1726). Responders had a better median survival time than non-responders (273 days [range 43–1728] vs 39 days [range 2–169]; P <0.001), whereas SAA concentrations were not associated with survival time. Lower haematocrit at presentation was associated with a reduced median survival time (P = 0.007). CONCLUSIONS AND RELEVANCE: In the population examined, no correlation between serum concentration of SAA and prognosis in patients with lymphoma was identified, while low haematocrit and lack of response to treatment were both found to be associated with survival time. SAA concentrations were elevated in patients with non-nasal lymphoma vs patients with tumours confined to the nasal cavity. SAGE Publications 2022-11-23 2022-12 /pmc/articles/PMC9742919/ /pubmed/36416277 http://dx.doi.org/10.1177/1098612X221135118 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Articles
Schiavo, Luca
Odatzoglou, Petros
Hare, Cassia
Williams, Tim L
Dobson, Jane M
Serum amyloid A and other clinicopathological variables in cats with intermediate- and large-cell lymphoma
title Serum amyloid A and other clinicopathological variables in cats with intermediate- and large-cell lymphoma
title_full Serum amyloid A and other clinicopathological variables in cats with intermediate- and large-cell lymphoma
title_fullStr Serum amyloid A and other clinicopathological variables in cats with intermediate- and large-cell lymphoma
title_full_unstemmed Serum amyloid A and other clinicopathological variables in cats with intermediate- and large-cell lymphoma
title_short Serum amyloid A and other clinicopathological variables in cats with intermediate- and large-cell lymphoma
title_sort serum amyloid a and other clinicopathological variables in cats with intermediate- and large-cell lymphoma
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742919/
https://www.ncbi.nlm.nih.gov/pubmed/36416277
http://dx.doi.org/10.1177/1098612X221135118
work_keys_str_mv AT schiavoluca serumamyloidaandotherclinicopathologicalvariablesincatswithintermediateandlargecelllymphoma
AT odatzogloupetros serumamyloidaandotherclinicopathologicalvariablesincatswithintermediateandlargecelllymphoma
AT harecassia serumamyloidaandotherclinicopathologicalvariablesincatswithintermediateandlargecelllymphoma
AT williamstiml serumamyloidaandotherclinicopathologicalvariablesincatswithintermediateandlargecelllymphoma
AT dobsonjanem serumamyloidaandotherclinicopathologicalvariablesincatswithintermediateandlargecelllymphoma